UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME
Sales, net	$ 12,866	$ 13,428	$ 25,386	$ 25,752
Cost of goods sold	5,127	5,277	9,805	10,069
Gross profit	7,739	8,151	15,581	15,683
Operating expense
Selling, general and administrative	3,181	2,959	6,440	5,846
Research & development	133	135	277	258
Total operating expenses	3,314	3,094	6,717	6,104
Operating income	4,425	5,057	8,864	9,579
Other income	747	142	1,428	150
Income before provision for income taxes	5,172	5,199	10,292	9,729
Provision for income taxes	972	1,096	1,878	2,091
Net income	$ 4,200	$ 4,103	$ 8,414	$ 7,638
Earnings per common share (basic)	$ 1.16	$ 1.13	$ 2.32	$ 2.09
Earnings per common share (diluted)	$ 1.15	$ 1.12	$ 2.31	$ 2.09
Shares outstanding - basic	3,628	3,643	3,628	3,649
Shares outstanding - diluted	3,639	3,650	3,638	3,658
Other comprehensive income (loss)
Foreign currency translation net of taxes of $0 in all periods	$ 504	$ (2,298)	$ 1,053	$ (2,804)
Total comprehensive income	$ 4,704	$ 1,805	$ 9,467	$ 4,834